Abingdon Health Plc (AIM:ABDX)

Abingdon Health Balance Sheet

Financials in millions GBP. Fiscal year is July - June.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	2.87	1.92	1.44	3.24	2.4
Cash & Short-Term Investments	2.87	1.92	1.44	3.24	2.4
Cash Growth	49.43%	33.19%	-55.50%	35.00%	-51.84%
Accounts Receivable	2.22	1.78	1.08	0.7	6.68
Other Receivables	1.17	0.91	0.58	0.5	1.35
Receivables	3.39	2.69	1.67	1.2	8.03
Inventory	0.74	0.53	0.44	0.33	0.53
Total Current Assets	6.99	5.13	3.55	4.76	10.96
Property, Plant & Equipment	1.15	1.04	1	1.26	1.78
Long-Term Investments	-	0.35	0.01	-	-
Goodwill	2.28	2.28	0.38	-	-
Other Intangible Assets	0.39	0.5	0.15	0.09	0.04
Long-Term Deferred Charges	-	0	0	-	-
Total Assets	10.81	9.31	5.09	6.11	12.77

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Accounts Payable	0.83	0.77	0.61	1.11	2.47
Accrued Expenses	0.62	0.43	0.5	0.69	0.94
Current Portion of Long-Term Debt	0.15	0.09	-	-	0.12
Current Portion of Leases	0.24	0.17	0.12	0.09	0.15
Current Income Taxes Payable	0.29	0.31	0.1	0.1	1.2
Current Unearned Revenue	1.42	0.69	0.4	0.05	0.44
Other Current Liabilities	0.12	0.46	0.11	0.09	-
Total Current Liabilities	3.66	2.92	1.82	2.12	5.32
Long-Term Debt	0.6	0.65	0.72	0.71	0.44
Long-Term Leases	0.36	0.12	0.21	0.22	0.58
Other Long-Term Liabilities	0.09	0.33	0.09	0.09	-
Total Liabilities	4.71	4.01	2.84	3.14	6.34

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Common Stock	0.06	0.05	0.03	0.03	0.03
Additional Paid-In Capital	40.43	37.04	30.81	30.31	30.31
Retained Earnings	-34.65	-32.17	-28.76	-27.49	-24.11
Comprehensive Income & Other	0.27	0.38	0.17	0.13	0.2
Shareholders' Equity	6.1	5.3	2.25	2.97	6.43
Total Liabilities & Equity	10.81	9.31	5.09	6.11	12.77

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Total Debt	1.34	1.03	1.05	1.02	1.28
Net Cash (Debt)	1.52	0.89	0.39	2.22	1.12
Net Cash Growth	71.24%	127.62%	-82.36%	98.48%	-67.92%
Net Cash Per Share	0.00	0.00	0.00	0.01	0.00
Filing Date Shares Outstanding	435.07	375.95	309.03	304.03	304.03
Total Common Shares Outstanding	435.07	375.95	309.03	304.03	304.03
Working Capital	3.34	2.21	1.72	2.64	5.63
Book Value Per Share	0.01	0.01	0.01	0.01	0.02
Tangible Book Value	3.43	2.52	1.72	2.88	6.4
Tangible Book Value Per Share	0.01	0.01	0.01	0.01	0.02
Machinery	4.98	4.81	4.59	6.49	6.45
Leasehold Improvements	3.75	3.75	3.64	3.64	3.62

Data Source: S&P Global Market Intelligence Last updated: Oct 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 24, 2026

Data Sources Report a data error